2Heidenreich PA,Lee TT,Massie BM.Effects of beta-blockade on mortality in patients with heart failure:a meta-analysis of randomized clinical trials.J Am Coll Cardiol,1997,30:27-34.
3Lechat P,Packer M,Chalon S,et al.Beta-blockers in heart failure:meta-analysis of randomized trial.Circulation,1998,98:1184-1191.
4Advisory Council to Improve Outcomes Nationwide in Heart Failure.Consensus recommendations for the management of chronic heart failure.Am J Cardiol,1999,83:1-38.
5Kurrelmeyer K,Kalra D,Bozkurt B,et al.Cardiac remodeling as a conse-quence and cause of progressive heart failure.Clin Cardiol,1998,21:14-19.
6Hjlamaeson A,Wagstein F.The role of beta-blokoers in the treatment of cardiong opathy.Drugs,1994,47:37-45.
4Waagstein F, Hjalmarson A, Varnauskas E, et al. Effects of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J, 1975,37: 1022-1036.
5Packer M. Beta-blockade in the management of chronic heart failure. Eur Heart J, 1996, 17(Suppl B) :21-23.
6Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet, 1993,342: 1444-1446.
7The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 1991,325:293-302.
8Hampton JR. Beta-blockade in heart failure: the evidence from clinical trials.Eur Heart J, 1996, 17(Suppl B) : 17-20.
9Shakar F, Abraham WT, Gilbert EM, et al. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Collcardiol, 1998,31 : 1336-1340.
1Rizos I.Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration.Am Heart J,2000,139:S120-123.
3Ferrari R,Merli E,Cicchitelli G,et al.Therapeutic effects ofL-carnitine and propionyl-L-carnitine on cardiovascular diseases.Ann NY Acad Sci,2004,1033:79-91.
4CalvaniM,Reda E,Arrigoni-Martelli E.Regulation by carni-tine of myocardial fatty acid and carbohydrate metabolism undernormal and pathological conditions.Basic Res Cardiol,2000,95:75-83.
5Kobayashi A,Masumura Y,Yamazaki N.L-carnitine treat-ment for congestive heart failure:experimental and clinical study.Japanese Cir J,1992,56:86-91.
